IDSA warns of potential loss of US measles elimination status - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

IDSA warns of potential loss of US measles elimination status

  • By

  • Kerri Ann DeCindis

  • November 12, 2026

  • 2 min

Share

Clinical Scorecard: IDSA warns of potential loss of US measles elimination status

At a Glance

Category

Detail

Condition

Measles and the expected loss of U.S. measles elimination status

Key Mechanisms

Elimination means continuous transmission has been interrupted for at least 12 months; loss of status would signal reestablished sustained transmission.

Target Population

U.S. communities affected by measles, with particular concern about long-term consequences for infants who contract the infection

Care Setting

U.S. public health response, including state and local health departments and infectious diseases specialists

Key Highlights

  • IDSA warned that the expected loss of U.S. measles elimination status would reverse decades of public health progress.

  • Findings presented at IDWeek 2026 showed a 284.5% increase in measles PCR testing volume and a 71.6% increase in positivity rates from April 2025 through March 2026 compared with the preceding year.

  • According to IDSA’s statement, more than 5,000 people had been diagnosed with measles and eight deaths had been reported in the United States in 2026.

  • IDSA President Wendy S. Armstrong, MD, FIDSA, highlighted potential long-term consequences for infants who contract measles, including a potentially fatal neurologic complication that can develop years after infection.

  • Armstrong urged stronger vaccination efforts, collaboration with the Pan American Health Organization, increased health department funding and expanded support for infectious diseases specialists.

Guideline-Based Recommendations

The source reports an IDSA public health statement and selected testing findings rather than a clinical guideline.

Diagnosis

  • The article cites increases in measles PCR testing volume and positivity rates during the reported period.

  • It does not provide a diagnostic algorithm, testing indications or specimen-collection recommendations.

Management

  • Armstrong urged government leaders to promote measles vaccination and strengthen disease prevention efforts.

  • She called for increased funding for state and local health departments and expanded support for infectious diseases specialists.

  • The source does not describe medication regimens or individual patient treatment.

Monitoring & Follow-up

  • Armstrong called for collaboration with the Pan American Health Organization to restore elimination status.

  • The article explains that elimination requires interruption of continuous transmission for at least 12 months.

  • It does not specify individual patient follow-up schedules.

Risks

  • IDSA described the reemergence of measles as a threat to communities nationwide and cited preventable deaths.

  • Armstrong raised concerns about potentially fatal neurologic disease developing years after infection in infants who contract measles.

  • Loss of elimination status would signal sustained transmission; the source describes that loss as expected, not confirmed.

Patient & Prescribing Data

IDSA reported more than 5,000 measles diagnoses and eight deaths in the United States in 2026.

The testing findings cover April 2025 through March 2026 and represent comparisons with the preceding year. They concern testing volume and positivity rates, rather than a reported percentage increase in national case counts.

The article provides no prescribing data, vaccine dosing schedule or medication treatment regimen.

Clinical Best Practices

  • Promote measles vaccination and disease prevention, as urged by Armstrong.

  • Support state and local health departments and infectious diseases specialists.

  • Collaborate with the Pan American Health Organization on restoring elimination status.

  • Preserve the distinction between increased testing, increased positivity and reported diagnoses when communicating the findings.

Related Resources & Content

  • IDSA warns of potential loss of US measles elimination status — Kerri Ann DeCindis — IDSA Reporter — November 12, 2026 — Source article.

  • U.S. loss of measles elimination status would be a major public health setback — Wendy S. Armstrong — Infectious Diseases Society of America — Updated November 12, 2026 — IDSA statement. idsociety.org

  • Measles testing, positivity rates continue to rise nationwide — Julia Cipriano — IDSA Reporter — October 21, 2026 — Related report. idsareporter.com

  • About Measles — Centers for Disease Control and Prevention — CDC, Measles (Rubeola) — April 29, 2026 — CDC overview.

Original Source(s)

Related Content